LifeMD, Inc.

NASDAQ:LFMD

Medical - Pharmaceuticals

Healthcare
$1.70 -3.27%

-$0.16 today

Market cap
$82.17M
Beta
1.99
P/E (TTM)
-13.8
EPS (TTM)
-$0.34
52W Low $2.56High $15.84

Volume 0.80M

Average 1.04M

LFMD Income Tax Expense

Income taxes recognized for the period, including current and deferred tax.

LifeMD, Inc.NASDAQ: LFMD

Income Tax Expense · Q1 FY2026 · quarter ended Mar 2026

Income tax expense remains negative

Q1 FY2026 income tax expense was $0, compared with $0 a year earlier. Trailing-twelve-month income tax expense was $183.03K. Over 3 fiscal years it compounded at -49.8% a year.

Context

  • Income tax expense amounted to 0.0% of revenue in FY2025, down 0.2 pp from a year earlier.
  • Income tax expense increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly income tax expense holds near $0 or moves back toward the trailing-twelve-month quarterly average of $45.76K.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0-100.0% QoQ
Last fiscal yearDec 2025
$45.72K-88.6% YoY
LTMMar 2026
$183.03K-54.5% YoY
Income Tax Expense past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year-88.6%——
3-year CAGR-49.8%——
5-year CAGR——
10-year CAGR——

Income Tax Expense history

USD · from the income statement

Latest · FY2025
45.72K USD
Year-over-year change
-88.6%
4-year CAGR
+56.1%

Income Tax Expense vs competitors

How LFMD compares with its peers on the latest reported figures

  • Peers report in different currencies, so income tax expense is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -54.5% is the 4th highest of 8, against a peer median of -62.5%.
  • Income tax expense amounts to 0.1% of revenue for LFMD, versus a peer median of 0.0%.
LFMD Competitors
Income Tax Expense for LFMD and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CERSCerus CorporationLTM Mar 2026$371K USD+81.0%-10.1%0.2%
HITIHigh Tide Inc.LTM Apr 2026CA$225.96K CAD-62.5%—0.0%
LFMDLifeMD, Inc.LTM Mar 2026$183.03K USD-54.5%-49.8%0.1%
TKNOAlpha Teknova, Inc.LTM Mar 2026$83K USD+359.4%—0.2%
SENSSenseonics Holdings, Inc.LTM Mar 2026$0 USD——0.0%
SMTISanara MedTech Inc.LTM Mar 2026$0 USD——0.0%
CVRXCVRx, Inc.LTM Mar 2026-$14K USD-216.7%—0.0%
SGHTSight Sciences, Inc.LTM Mar 2026-$20K USD-107.7%-40.3%0.0%
MASS908 Devices Inc.LTM Mar 2026-$66K USD+7.0%—0.1%
TBRGTruBridge, Inc.LTM Mar 2026-$4.87M USD-129.5%—1.4%
Peer median (excluding LFMD) —-62.5%-25.2%0.0%

Competitors are the stored peer set for LFMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue92.88M119.03M152.55M212.45M194.06M
Cost of Revenue18M18.67M18.9M24.07M39.29M
Gross Profit74.88M100.37M133.65M188.39M154.76M
Gross Margin80.6%84.3%87.6%88.7%79.8%
Research & Development948.16K2.97M6.06M9.51M7.35M
Selling, General & Admin122.08M125.33M128.15M175.68M144.01M
Operating Expenses129.18M143.81M148.14M204.53M162.43M
Depreciation & Amortization355.87K1.09M6.6M9.49M7.31M
EBITDA(57.94M)(38.6M)(8.21M)(6.65M)(1.52M)
EBITDA Margin-62.4%-32.4%-5.4%-3.1%-0.8%
Operating Income(54.3M)(43.45M)(14.49M)(16.14M)(7.67M)
Operating Margin-58.5%-36.5%-9.5%-7.6%-4.0%
Interest Income00000
Interest Expense3.02M1.28M2.6M2.18M1.36M
Other Income / Expenses(7.02M)(1.21M)(2.92M)(2.18M)(2.52M)
Income Before Tax(61.32M)(44.66M)(17.41M)(18.33M)(10.19M)
Pre-Tax Margin-66.0%-37.5%-11.4%-8.6%-5.2%
Income Tax Expense7.7K360.7K428K402K45.72K
Net Income(60.9M)(45.54M)(20.6M)(18.88M)(7.11M)
Net Margin-65.6%-38.3%-13.5%-8.9%-3.7%
EPS (Basic)(2.27)(1.57)(0.70)(0.53)(0.23)
EPS (Diluted)(2.27)(1.57)(0.70)(0.53)(0.23)
Weighted Avg Shares27.01M30.98M33.91M41.2M45.13M
Weighted Avg Shares (Diluted)27.01M30.98M33.91M41.2M45.13M

LifeMD, Inc.

NASDAQ:LFMD

Intrinsic Alpha fair value

Locked

Current Price

$1.70

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.